Drug Shortage Report for VINORELBINE INJECTION, USP

Last updated on 2019-09-10 History
Report ID 89588
Drug Identification Number 02431130
Brand name VINORELBINE INJECTION, USP
Common or Proper name Vinorelbine for Injection
Company Name GENERIC MEDICAL PARTNERS INC
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5 ml Vial. Each pack contains one vial.
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-07-01
Actual start date 2019-07-01
Estimated end date 2019-10-01
Actual end date
Shortage status Actual shortage
Updated date 2019-09-10
Company comments GMP has removed the 75% allocation on Vinorelbine 10 mg/ml 5 ml vials for all contracted accounts and all direct orders. A further increase in stock level is anticipated at the end of September that should result in all restrictions on supply being removed.
Health Canada comments
Contact Address 1500 DON MILLS ROAD, SUITE 406
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-09-10 French Compare
v8 2019-09-10 English Compare
v7 2019-09-10 English Compare
v6 2019-09-10 English Compare
v5 2019-07-18 French Compare
v4 2019-07-18 English Compare
v3 2019-07-18 English Compare
v2 2019-07-18 English Compare
v1 2019-07-18 English Compare